EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Vascular endothelial growth factor-targeted therapy in patients with renal cell carcinoma pretreated with immune checkpoint inhibitors: A systematic literature review

Laurence Albiges, Bradley A McGregor, Daniel Y C Heng, Giuseppe Procopio, Guillermo de Velasco, Naila Taguieva-Pioger, Lidia Martín-Couce, Nizar M Tannir, Thomas Powles

Cancer Treatment Reviews · 2024

DOI: 10.1016/j.ctrv.2023.102652 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cancer Treatment Reviews, 2024. Verfasst von Laurence Albiges und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France. Electronic address: laurence.albiges@gustaveroussy.fr. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Vascular Endothelial Growth Factor A. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ipsen, Ipsen Ltd UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsVascular Endothelial Growth Factor AHumansAngiogenesis InhibitorsImmune Checkpoint InhibitorsAnilidesPyridines

Stichwörter der Autor:innen

Checkpoint inhibitorsRenal cell carcinomaTyrosine kinase inhibitorVascular endothelial growth factor

Substanzen

Angiogenesis InhibitorsImmune Checkpoint InhibitorsVascular Endothelial Growth Factor AcabozantinibAnilidesPyridines

Autor:innen und Institutionen

  • Medical Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France. Electronic address: laurence.albiges@gustaveroussy.fr.
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Division of Medical Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada.
  • Genitourinary Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • University Hospital 12 de Octubre, Department of Medical Oncology, Madrid, Spain.
  • Ipsen, Boulogne-Billancourt, France.

Förderung

  • Ipsen
  • Ipsen Ltd UK

Zitieren

APA

Albiges, L., McGregor, B. A., Heng, D. Y. C., Procopio, G., de Velasco, G., Taguieva-Pioger, N., Martín-Couce, L., Tannir, N. M., & Powles, T. (2024). Vascular endothelial growth factor-targeted therapy in patients with renal cell carcinoma pretreated with immune checkpoint inhibitors: A systematic literature review. Cancer Treatment Reviews. https://doi.org/10.1016/j.ctrv.2023.102652

Vancouver

Albiges L, McGregor BA, Heng DYC, Procopio G, de Velasco G, Taguieva-Pioger N, et al. Vascular endothelial growth factor-targeted therapy in patients with renal cell carcinoma pretreated with immune checkpoint inhibitors: A systematic literature review. Cancer Treatment Reviews. 2024. doi:10.1016/j.ctrv.2023.102652

BibTeX
@article{Albiges2024,
  author = {Albiges, Laurence and McGregor, Bradley A and Heng, Daniel Y C and Procopio, Giuseppe and de Velasco, Guillermo and Taguieva-Pioger, Naila and Martín-Couce, Lidia and Tannir, Nizar M and Powles, Thomas},
  title = {Vascular endothelial growth factor-targeted therapy in patients with renal cell carcinoma pretreated with immune checkpoint inhibitors: A systematic literature review},
  journal = {Cancer Treatment Reviews},
  year = {2024},
  doi = {10.1016/j.ctrv.2023.102652}
}
Kostenlos starten →